HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

G Hesse Selected Research

4-amino-4'-hydroxylaminodiphenylsulfone (HADS)

2/2017Catamnesis results of an inpatient neuro-otologic and psychosomatic tinnitus therapy 1-5 years after discharge.
8/2015[Pre- and posttreatment results of an inpatient neurotologic and psychosomatic tinnitus therapy].
6/2015Patients with long-lasting dizziness: a follow-up after neurotological and psychotherapeutic inpatient treatment after a period of at least 1 year.
1/2009[Psychosocial aspects of coping with tinnitus and psoriasis patients. A comparative study of suicidal tendencies, anxiety and depression].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


G Hesse Research Topics

Disease

15Tinnitus
05/2018 - 09/2001
6Hearing Loss (Hearing Impairment)
02/2017 - 10/2010
1Sensorineural Hearing Loss
12/2015
1Deafness (Deaf Mutism)
06/2015
1Dizziness (Lightheadedness)
06/2015
1Dementia (Dementias)
09/2014
1Pathologic Processes
10/2010
1Exophthalmos (Proptosis)
07/2009
1Psoriasis (Pustulosis Palmaris et Plantaris)
01/2009
1Hallucinations (Hallucination)
07/2008
1Schizophrenia (Dementia Praecox)
07/2008
1Neoplasms (Cancer)
06/2002
1Hashimoto Disease (Thyroiditis, Hashimoto)
10/2001
1Addison Disease (Addison's Disease)
10/2001
1Autoimmune Diseases (Autoimmune Disease)
10/2001
1Nevus (Nevi)
10/2001
1Autoimmune Polyendocrinopathies (Schmidt Syndrome)
10/2001
1Hyperpigmentation
10/2001
1Auditory Perceptual Disorders (Auditory Processing Disorder)
08/2001
1Perceptual Disorders (Hemispatial Neglect)
08/2001
1Wounds and Injuries (Trauma)
10/2000

Drug/Important Bio-Agent (IBA)

44-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
02/2017 - 01/2009
2Therapeutic UsesIBA
02/2017 - 08/2015
1ElementsIBA
02/2017
1Fibrinogen (Factor I)FDA Link
12/2015
1serum P-component (CIt)IBA
06/2015
1PlasticsIBA
10/2010
1Psychotropic Drugs (Psychoactive Drugs)IBA
10/2010
1SteroidsIBA
10/2010
1Antipsychotic Agents (Antipsychotics)IBA
07/2008
1Capsules (Microcapsules)IBA
06/2002
1Adrenocorticotropic Hormone (ACTH)FDA Link
10/2001
1Hormones (Hormone)IBA
10/2001
1Hydrocortisone (Cortisol)FDA LinkGeneric
10/2001
1Thyroxine (Levothyroxine)FDA LinkGeneric
10/2001

Therapy/Procedure

16Therapeutics
05/2018 - 08/2001
4Hearing Aids (Hearing Aid)
02/2017 - 10/2010
2Cochlear Implants (Cochlear Implant)
06/2015 - 10/2010
1Blood Component Removal (Apheresis)
12/2015
1Combined Modality Therapy
09/2014
1Drug Therapy (Chemotherapy)
10/2010
1Conservative Treatment
07/2009
1Music Therapy
05/2007
1Continuous Ambulatory Peritoneal Dialysis (CAPD)
08/2001
1Air Bags (Airbags)
10/2000